FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (2187 ms)

ValueSets, Realm EU

337 resources

Source:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

By Version

By Authority

Rows 0 - 200 Next
PackageVersionIdentityName/TitleStatusDateAuthSource(s)
hl7.eu.fhir.xpandh.hdrR4TNM-M-category-vs TNM M Categoryactive2024-09hl7internal
hl7.eu.fhir.xpandh.hdrR4TNM-M-clinical-category-vs Clinical Mactive2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4TNM-M-pathologycal-category-vs Pathological Mactive2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4TNM-N-category-vs TNM N Categoryactive2024-09hl7internal
hl7.eu.fhir.xpandh.hdrR4TNM-N-clinical-category-vs Clinical Nactive2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4TNM-N-pathological-category-vs Pathological Nactive2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4TNM-T-category-vs Primary tumor Tactive2024-09hl7internal
hl7.eu.fhir.xpandh.hdrR4TNM-T-clinical-category-vs Clinical Tactive2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4TNM-T-pathological-category-vs Clinical Tactive2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4admission-voluntary-status-vs Encounter Voluntary Status Value Setdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4allergy-intolerance-substances-xpandh-vs AllergyIntoleranceSubstancesXpandhVSdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4allergy-intolerance-xpandh-vs Allergy Intolerance - Xpandhdraft2024-09hl7internal fhir
hl7.eu.fhir.xpandh.hdrR4anthropometric-observation-vs Anthropometric Observation Value Setdraft2024-09hl7internal sct
hl7.eu.fhir.xpandh.hdrR4assessment-observation-category-vs Xpandh Assessment Observation Categoryactive2024-09hl7internal
hl7.eu.fhir.xpandh.hdrR4bmi-observation-unit-vs BMI Observation Unit Value Setdraft2024-09hl7ucum
hl7.eu.fhir.xpandh.hdrR4bmi-observation-vs BMI Observation Value Setdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4body-height-observation-vs Body Height Observation Value Setdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4body-weight-observation-vs Body Weight Observation Value Setdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4body-weight-units-vs Body Weight Observation Value Setdraft2024-09hl7ucum
hl7.eu.fhir.xpandh.hdrR4cancer-stage-grading-vs Cancer Stage Grading: Snomed CTdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4cancer-stageGroup-vs Cancer Stage Group: SNOMED CTdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4circumference-observation-vs Circumference Observation Value Setdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4functional-assessment-scales-vs Xpandh Functional Assessment Scalesactive2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4hdr-admission-urgency-xpandh-vs Admission Urgency Value Setdraft2024-09hl7tho
hl7.eu.fhir.xpandh.hdrR4hdr-condition-mandatory-xpandh-vs Mandatory Condition Value Setdraft2024-09hl7internal fhir sct
hl7.eu.fhir.xpandh.hdrR4hdr-condition-xpandh-vs Condition Value Setdraft2024-09hl7sct icd
hl7.eu.fhir.xpandh.hdrR4hdr-encounter-type-xpandh-vs In-patient Encounter Type Value Setdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4hdr-encounterClass-xpandh-vs Encounter Class Value Setdraft2024-09hl7tho
hl7.eu.fhir.xpandh.hdrR4hdr-poa-indicator-xpandh-vs Condition Present on Admission (POA) Value Setdraft2024-09hl7internal
hl7.eu.fhir.xpandh.hdrR4hdr-treated-xpandh-vs Treatment Class Value Setdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-09hl7loinc
hl7.eu.fhir.xpandh.hdrR4mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-09hl7loinc
hl7.eu.fhir.xpandh.hdrR4mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-09hl7loinc
hl7.eu.fhir.xpandh.hdrR4medical-devices-snomed-absent-unknown-xpandh-vs Medical Devices - SNOMED CT + Absent/Unknown - IPSdraft2024-09hl7internal fhir
hl7.eu.fhir.xpandh.hdrR4medical-devices-xpandh-vs Medical Devices (SNOMED CT) - Xpandhdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4medication-snomed-absent-unknown-uv-ips Medications - SNOMED CT + Absent/Unknown (IPS)active2024-09hl7fhir sct
hl7.eu.fhir.xpandh.hdrR4procedure-snomed-xpandh-vs Procedure codes: Snomed CTdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4procedures-snomed-absent-unknown-xpandh-vs Procedures - SNOMED CT + Absent/Unknown - IPSdraft2024-09hl7fhir sct
hl7.eu.fhir.xpandh.hdrR4skinfold-thickness-units-vs Skinfold Thickness Units Value Setdraft2024-09hl7ucum
hl7.eu.fhir.xpandh.hdrR4skinfold-thickness-vs Skinfold Thickness Value Setdraft2024-09hl7sct
hl7.eu.fhir.xpandh.hdrR4vital-signs-observation-vs Vital Signs Observation Value Setdraft2024-09hl7internal sct
hl7.eu.fhir.xpandh.hdrR4whodas-code-vs Xpandh WHODAS Codes Valuesetactive2024-09hl7
hl7.eu.fhir.xpandh.hdrR4whodas-domain-vs Xpandh WHODAS Domain Valuesetactive2024-09hl7
hl7.eu.fhir.xpandh.hdrR4whodas-result-vs Xpandh WHODAS Result Valuesetactive2024-09hl7
hl7.eu.fhir.fluteR4VS-BiopsyType Type of Biopsydraft2024-06hl7sct
hl7.eu.fhir.fluteR4VS-DREOutcomeCode DRE Observation Interpretation Codesdraft2024-06hl7sct
hl7.eu.fhir.fluteR4VS-GleasonGrade Gleason Gradedraft2024-06hl7loinc
hl7.eu.fhir.fluteR4VS-PCa Malignant tumor of prostate Value Setdraft2024-06hl7sct
hl7.eu.fhir.fluteR4VS-PiRads Prostate Imaging – Reporting and Data Systemdraft2024-06hl7
hl7.eu.fhir.ghR53point-category-vs ThreepointCategoryVSactive2024-09hl7internal
hl7.eu.fhir.ghR5PDcategoryVS PDcategoryVSactive2024-09hl7
hl7.eu.fhir.ghR5PDtypeVS PDtypeVSactive2024-09hl7internal
hl7.eu.fhir.ghR5asm-category-vs ASMCategoryVSactive2024-09hl7internal
hl7.eu.fhir.ghR5type-of-data-vs TypeOfDataVSactive2024-09hl7internal
hl7.eu.fhir.idea4rcR4Gender-i4rc Gender: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4alcoholUsageStatus-athena-eu-i4rc Alcohol Usage Status: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4alcoholUsageStatus-snomed-eu-i4rc Alcohol Usage Status: SNOMED CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4beam-quality-i4rc Beam Qualityactive2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-chondroOsseousTumours-athena-vs Cancer Chondro Osseous Tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-diagnosis-athena-vs Cancer diagnosis: Athenadraft2024-07hl7internal
hl7.eu.fhir.idea4rcR4cancer-estAndRelatedTumours-athena-vs Cancer Endometrial stromal and related Tumors: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-event-type-vs Cancer Event Type: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-histologyAdenocarcinoma-athena-vs Cancer Histology Adenocarcinoma: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-histologyNeuroendocrine-athena-vs Cancer Histology Neuroendocrine: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-histologyOdontogenicCarcinoma-athena-vs Cancer Histology Odontogenic Carcinoma: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-histologySNUC-athena-vs Cancer Histology SNUC: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-histologySquamous-athena-vs Cancer Histology Squamous: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-histologySubgroupAdipocyticTumours-athena-vs Cancer Histology Subgroup Adipocytic Tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-histologySubgroupFmtTumours-athena-vs Cancer Histology Subgroup Fmt Tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-miscellaniousMesenchimalTumors-athena-vs Cancer Miscellanious mesenchimal tumors: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-mixedEpithelialAndMesenchymalTumours-athena-vs Cancer Mixed epithelial and mesenchymal tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-pericyticPerivascularTumours-athena-vs Cancer Pericytic Perivascular Tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-peripheralNerveSheathTumours-athena-vs Cancer Peripheral Nerve Sheath Tumors: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-skeletalMuscleTumours-athena-vs Cancer Skeletal Muscle Tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-smoothMuscleTumours-athena-vs Cancer Smooth Muscle Tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-socalledFibrohistiocyticTumours-athena-vs Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-stageGrading-athena-vs Cancer Stage Grading: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-stageGroup-athena-vs Cancer Stage Group: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-stageGroupValue-athena-vs Cancer Stage Group Value: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-tumoursOfUncertainDifferentiation-athena-vs Cancer Tumors Of Uncertain Differentiation: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-undifSmallRCelSarcBonAndSofTis-athena-vs Cancer undif. small round cell sarcomas of bone and soft tissue: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4cancer-vascularTumours-athena-vs Cancer Vascular Tumours: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4chemo-units-eu-i4rc Chemotherapy cumulative dose unitsdraft2024-07hl7ucum
hl7.eu.fhir.idea4rcR4comorbidities-athena-eu-i4rc Comorbidities: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4comorbidities-sct-eu-i4rc Comorbidities: SNOMEDactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4country-eu-i4rc Country: athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4disease-extent-category-vs Sarcoma Staging: localized diseasedraft2024-07hl7
hl7.eu.fhir.idea4rcR4drugsAtc-eu-i4rc Antineoplastic and immunostimulating agentsdraft2024-07hl7atc
hl7.eu.fhir.idea4rcR4ecog-i4rc ECOG Performance Statusactive2024-07hl7
hl7.eu.fhir.idea4rcR4event-type-eu-i4rc Event Typeactive2024-07hl7
hl7.eu.fhir.idea4rcR4extranodal-extension-i4rc Extranodal Extensiondraft2024-07hl7
hl7.eu.fhir.idea4rcR4geneticTestPerformed-eu-i4rc Genetic Tests performed (Yes/no/Unk)active2024-07hl7internal
hl7.eu.fhir.idea4rcR4genito-urinary-subsite-athena-i4rc Genito urinary subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4hypopharynx-subsite-athena-i4rc Hypopharynx subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4hypopharynx-subsite-sct-i4rc Hypopharynx subsite: Snomed CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4intra-abdominal-subsite-athena-i4rc Intra abdominal subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4intra-thoracic-subsite-athena-i4rc Intra thoracic subsite : Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4larynx-subsite-athena-i4rc Larynx subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4larynx-subsite-sct-i4rc Larynx subsite: Snomed CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4lip-subsite-athena-i4rc Lip subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4lip-subsite-sct-i4rc Lip subsite: Snomed CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4locoregional-category-vs Sarcoma Staging: loco-regional categorydraft2024-07hl7
hl7.eu.fhir.idea4rcR4margins-after-surgery-eu-i4rc Margins After Surgeryactive2024-07hl7
hl7.eu.fhir.idea4rcR4mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-07hl7loinc
hl7.eu.fhir.idea4rcR4mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-07hl7loinc
hl7.eu.fhir.idea4rcR4mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-07hl7loinc
hl7.eu.fhir.idea4rcR4mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-07hl7
hl7.eu.fhir.idea4rcR4mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-07hl7
hl7.eu.fhir.idea4rcR4mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-07hl7
hl7.eu.fhir.idea4rcR4metastasis-disorder-athena-vs Metastatis: Athenadraft2024-07hl7
hl7.eu.fhir.idea4rcR4nasal-paranasal-subsite-athena-i4rc Nasal cavity and paranasal sinuses subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4nasal-paranasal-subsite-sct-i4rc Nasal cavity and paranasal sinuses subsite: Snomed CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4nasal-subsite-athena-i4rc Subsites: Athenaactive2024-07hl7internal
hl7.eu.fhir.idea4rcR4nasal-subsite-sct-i4rc Subsites: SNOMED CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4nasopharynx-subsite-athena-i4rc Nasopharynx subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4nasopharynx-subsite-sct-i4rc Nasopharynx subsite: Snomed CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4obsYesNo-code-eu-i4rc Types of Yes/No observationsactive2024-07hl7internal
hl7.eu.fhir.idea4rcR4occurrence-other-cancer-i4rc Occurrence of other canceractive2024-07hl7
hl7.eu.fhir.idea4rcR4oralCavity-subsite-athena-i4rc Oral cavity subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4oralCavity-subsite-sct-i4rc Oral cavity subsite: Snomed CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4oropharynx-subsite-athena-i4rc Oropharynx subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4oropharynx-subsite-sct-i4rc Oropharynx subsite: Snomed CTactive2024-07hl7sct
hl7.eu.fhir.idea4rcR4pathologicalM-i4rc Pathological Mactive2024-07hl7
hl7.eu.fhir.idea4rcR4pathologicalN-i4rc Pathological Nactive2024-07hl7
hl7.eu.fhir.idea4rcR4pathologicalT-i4rc Pathological Tactive2024-07hl7
hl7.eu.fhir.idea4rcR4pos-neg-nt-athena-eu-i4rc Positive-Negative-No Test: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4race-i4rc Raceactive2024-07hl7
hl7.eu.fhir.idea4rcR4reason-for-end-of-treatment-eu-i4rc Reason For End Of Treatmentactive2024-07hl7
hl7.eu.fhir.idea4rcR4setting-radiotherapy-i4rc Setting Radiotherapyactive2024-07hl7
hl7.eu.fhir.idea4rcR4simpleResult-eu-i4rc Simple measuresactive2024-07hl7
hl7.eu.fhir.idea4rcR4site-of-metastasis-i4rc Site of metastasisactive2024-07hl7
hl7.eu.fhir.idea4rcR4site-qualifier-i4rc Body site qualifieractive2024-07hl7
hl7.eu.fhir.idea4rcR4siteRare-i4rc Site rare (IDEA4RC)active2024-07hl7sct
hl7.eu.fhir.idea4rcR4smokingStatus-athena-eu-i4rc Current Smoking Status: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4smokingStatus-loinc-eu-i4rc Smoking Status: LOINCactive2024-07hl7loinc
hl7.eu.fhir.idea4rcR4status-last-followup-i4rc Status at the Last Follow Upactive2024-07hl7internal
hl7.eu.fhir.idea4rcR4surgery-complication-eu-i4rc Surgery Complicationactive2024-07hl7
hl7.eu.fhir.idea4rcR4surgery-intention-eu-i4rc Surgery Intentionactive2024-07hl7
hl7.eu.fhir.idea4rcR4surgery-outcome-eu-i4rc Surgery Outcomeactive2024-07hl7
hl7.eu.fhir.idea4rcR4surgical-complications-eu-i4rc Surgical Complicationsactive2024-07hl7
hl7.eu.fhir.idea4rcR4tobacco-product-eu-i4rc Tobacco Productactive2024-07hl7
hl7.eu.fhir.idea4rcR4treatment-completed-as-planned-i4rc Treatment completed as plannedactive2024-07hl7
hl7.eu.fhir.idea4rcR4treatment-response-eu-i4rc Treatment Responseactive2024-07hl7
hl7.eu.fhir.idea4rcR4treatment-setting-eu-i4rc Treatment Settingactive2024-07hl7
hl7.eu.fhir.idea4rcR4treatment-technique-i4rc Treatment Techniqueactive2024-07hl7
hl7.eu.fhir.idea4rcR4trunk-wall-subsite-athena-i4rc Trunk wall subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4type-of-biopsy-eu-i4rc Type of Biopsyactive2024-07hl7
hl7.eu.fhir.idea4rcR4type-of-diagnosis-eu-i4rc Type of Diagnosisactive2024-07hl7tho
hl7.eu.fhir.idea4rcR4type-of-surgical-approach-eu-i4rc Type of surgical approachactive2024-07hl7
hl7.eu.fhir.idea4rcR4type-of-systemic-treatment-eu-i4rc Type of Systemic Treatmentactive2024-07hl7
hl7.eu.fhir.idea4rcR4type-of-treatment-eu-i4rc Type of Treatmentactive2024-07hl7
hl7.eu.fhir.idea4rcR4upperLower-limbs-subsite-athena-i4rc Upper and Lower limbs subsite: Athenaactive2024-07hl7
hl7.eu.fhir.idea4rcR4vs-affectedOrgan-eu-i4rc Affected Organs (surgery)active2024-07hl7fhir tho
hl7.eu.fhir.idea4rcR4vs-calcest-eu-i4rc Calculated|Estimateddraft2024-07hl7fhir sct
hl7.eu.fhir.idea4rcR4vs-npunk-eu-i4rc Not Performed|Unknowndraft2024-07hl7fhir
hl7.eu.fhir.idea4rcR4vs-radiotherapyDeviceType-eu-i4rc Radiotherapy Device Typedraft2024-07hl7internal
hl7.eu.fhir.idea4rcR4vs-surgicalProcedureCategory-eu-i4rc Surgical Procedure Categoryactive2024-07hl7
hl7.eu.fhir.idea4rcR4vs-surgicalProcedureType-eu-i4rc Surgical Procedure Typeactive2024-07hl7fhir
hl7.eu.fhir.idea4rcR4yes-no-unk-athena-eu-i4rc Yes-No-Unk: Athenaactive2024-07hl7
hl7.eu.fhir.unicomR5administration-device EDQM Administration Deviceactive2024-07hl7
hl7.eu.fhir.unicomR5administration-method EDQM Administration Methodactive2024-07hl7
hl7.eu.fhir.unicomR5all-units-vs EMA SPOR All Units Combineddraft2024-07hl7
hl7.eu.fhir.unicomR5atc-spor-vs EMA SPOR ATCdraft2024-07hl7
hl7.eu.fhir.unicomR5authorised-doseform-vs EMA SPOR Authorised Dose Formdraft2024-07hl7
hl7.eu.fhir.unicomR5basic-dose-form EDQM Basic Dose Formactive2024-07hl7
hl7.eu.fhir.unicomR5closure EDQM Closureactive2024-07hl7
hl7.eu.fhir.unicomR5combination-pack EDQM Combination Packactive2024-07hl7
hl7.eu.fhir.unicomR5combined-pharmaceutical-dose-form EDQM Combined Pharmaceutical Dose Formactive2024-07hl7
hl7.eu.fhir.unicomR5combined-term EDQM Combined Termactive2024-07hl7
hl7.eu.fhir.unicomR5container EDQM Containeractive2024-07hl7
hl7.eu.fhir.unicomR5country-ema-vs EMA SPOR Countrydraft2024-07hl7
hl7.eu.fhir.unicomR5country-iso-vs Country (ISO 3166-1-2)draft2024-07hl7
hl7.eu.fhir.unicomR5domain-vs EMA SPOR Domaindraft2024-07hl7
hl7.eu.fhir.unicomR5ehdsi-ucum-unit MyHealth@EU Unit of Measurement (UCUM)active2024-07hl7ucum
hl7.eu.fhir.unicomR5intended-site EDQM Intended Siteactive2024-07hl7
hl7.eu.fhir.unicomR5language-bcp-vs Language (FHIR)draft2024-07hl7fhir
hl7.eu.fhir.unicomR5language-ema-vs EMA SPOR Languagedraft2024-07hl7
hl7.eu.fhir.unicomR5legal-status-for-the-supply-vs EMA SPOR Legal Status for the Supplydraft2024-07hl7
hl7.eu.fhir.unicomR5marketing-status-spor-vs EMA SPOR Marketing Statusdraft2024-07hl7
hl7.eu.fhir.unicomR5material-vs EMA SPOR Materialdraft2024-07hl7
hl7.eu.fhir.unicomR5packaging-category EDQM Packaging Categoryactive2024-07hl7
hl7.eu.fhir.unicomR5packaging-spor-vs EMA SPOR Packagingdraft2024-07hl7
hl7.eu.fhir.unicomR5patient-friendly-term EDQM Patient-friendly Termactive2024-07hl7
hl7.eu.fhir.unicomR5pharmaceutical-dose-form EDQM Pharmaceutical Dose Formactive2024-07hl7
hl7.eu.fhir.unicomR5pharmaceutical-doseform-vs EMA SPOR Pharmaceutical Dose Formdraft2024-07hl7
hl7.eu.fhir.unicomR5record-status-spor-vs EMA SPOR Record Statusdraft2024-07hl7
hl7.eu.fhir.unicomR5regulatory-status-spor-vs EMA SPOR Regulatory Entitlement Statusdraft2024-07hl7
hl7.eu.fhir.unicomR5route-of-administration EDQM Route of Administrationactive2024-07hl7
hl7.eu.fhir.unicomR5routes-and-methods-of-administration-vs EMA SPOR Routes and Methods of Administrationdraft2024-07hl7
hl7.eu.fhir.unicomR5shelflifetype-spor-vs EMA SPOR Shelf Life Typedraft2024-07hl7
hl7.eu.fhir.unicomR5substances-vs EMA SPOR SMS Substancesdraft2024-07hl7
hl7.eu.fhir.unicomR5unit-of-measurement-vs EMA SPOR Unit of Measurementdraft2024-07hl7
hl7.eu.fhir.unicomR5unit-of-presentation-vs EMA SPOR Unit of Presentationdraft2024-07hl7
hl7.eu.fhir.unicomR5unit-of-presentation EDQM Unit of Presentationactive2024-07hl7
hl7.eu.fhir.unicomR5whoatc-unicom WHO ATCactive2024-07hl7atc
hl7.fhir.eu.laboratoryR4lab-certifiedRefMaterial-eu-lab Laboratory Certified Reference Materialdraft2024-09hl7
hl7.fhir.eu.laboratoryR4lab-laterality-eu-lab Body Structure Lateralitydraft2024-09hl7sct
hl7.fhir.eu.laboratoryR4lab-obsCode-eu-lab Laboratory Codedraft2024-09hl7internal
hl7.fhir.eu.laboratoryR4lab-obsCode-loinc-eu-lab Laboratory Code: LOINCdraft2024-09hl7loinc
hl7.fhir.eu.laboratoryR4lab-obsCode-npu-eu-lab Laboratory Code: NPUdraft2024-09hl7

XIG built as of 07 Sep 2024. Found 38492 resources in 657 packages.